Immunohistochemical detection of 13(R)-hydroxyoctadecadienoic acid in atherosclerotic plaques of human carotid arteries using a novel specific antibody

Acta Histochemica et Cytochemica

Volumn 42, Issue 6, 2009, Pages 197-203

  Shibata, Noriyuki ^a   Toi, Sono ^a   Shibata, Takahiro ^b   Uchida, Koji ^b   Itabe, Hiroyuki ^c   Sawada, Tatsuo ^a   Kawamata, Takakazu ^d   Okada, Yoshikazu ^a   Uchiyama, Shinichiro ^a   Kobayashi, Makio ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b NAGOYA UNIVERSITY   (Japan)

^c SHOWA UNIVERSITY   (Japan)

^d Tokyo Women s Medical University   (Japan)

Author keywords

13(R) hydroxyoctadecadienoic acid; Carotid atherosclerosis; Enzyme linked immunosorbent assay; Immunohistochemistry; Monoclonal antibody

Indexed keywords

BOVINAE;

EID: 72849112433     PISSN: 00445991     EISSN: 13475800     Source Type: Journal    
DOI: 10.1267/ahc.09022     Document Type: Article

References (25)

1. Baer, A. N., Costello, P. B. and Green, F. A. (1991) Stereo-specificity of the hydroxyeicosatetraenoic and hydroxyoctadecadienoic acids produced by cultured bovine endothelial cells. Biochim. Biophys. Acta 1085; 45-52.
2. Birukov, K. G. (2006) Oxidized lipids: the two faces of vascular inflammation. Curr. Atheroscler. Rep. 8; 223-231.
3. Buchanan, M. R., Haas, T. A., Lagarde, M. and Guichardant, M. (1985) 13-Hydroxyoctadecadienoic acid is the vessel wall chemorepellant factor, LOX. J. Biol. Chem. 260; 16056-16059.
4. Buchanan, M. R., Bertomeu, M. C., Haas, T. A., Orr, W. and Eltringham-Smith, L. L. (1993) Localization of 13-hydroxyoctadecadienoic acid and the vitronectin receptor in human endothelial cells and endothelial cell/platelet interactions in vitro. Blood 81; 3303-3312.
5. Fearon, I. M. and Faux, S. P. (2009) Oxidative stress and cardiovascular disease: novel tools give (free) radical insight. J. Mol. Cell. Cardiol. 47; 372-381.
6. Feinmark, S. J. and Cornicelli, J. A. (1997) Is there a role for lipoxygenase in atherogenesis? Biochem. Pharmacol. 54; 953-959.
7. Grabarek, Z. and Gergely, J. (1990) Zero-length crosslinking procedure with the use of active esters. Anal. Biochem. 185; 131-135.
8. Hübke, H., Garbe, L.-A. and Tressl, R. (2005) Characterization and quantification of free and esterified 9-and 13-hydroxyoctadecadienoic acids (HODE) in barley, germinating barley, and finished malt. J. Agric. Food Chem. 53; 1556-1562.
9. Itabe, H., Takeshima, E., Iwasaki, H., Kimura, J., Yoshida, Y., Imanaka, T. and Takano, T. (1994) A monoclonal antibody against oxidized lipoprotein recognizes foam cells in atheroscle-rotic lesions. J. Biol. Chem. 269; 15274-15279.
10. Jostarndt, K., Gellert, N., Rubic, T., Weber, C., Kühn, H., Johansen, B., Hrboticky, N. and Neuzil, J. (2002) Dissociation of apoptosis induction and CD36 upregulation by enzymatically modified low-density lipoprotein in monocytic cells. Biochem. Biophys. Res. Commun. 290; 988-993.
11. Kaduce, T. L., Figard, P. H., Leifur, R. and Spector, A. A. (1989) Formation of 9-hydroxyoctadecaenoic acid from linoleic acid in endothelial cells. J. Biol. Chem. 264; 6823-6830.
12. Lagarde, M., Boutillon, M. M., Guichardant, M., Lellouche, J. P., Beaucourt, J. P., Vanhove, A. and Grée, R. (1989) Further studies on the anti-thromboxane A2 activity of monohydroxylated fatty acids. Biochem. Pharmacol. 38; 1863-1864.
13. Liu, B., Timar, J., Howlett, J., Diglio, C. A. and Honn, K. V. (1991) Lipoxygenase metabolites of arachidonic and linoleic acids modulates the adhesion of tumor cells to endothelium via regulation of protein kinase C. Cell Regul. 2; 1045-1055.
14. Marx, N., Bourier, T., Sulhova, G. K. and Plutzky, J. (1999) PPARγ activation in human endothelial cells increases plasmino-gen activator inhibitor type-1 expression. PPARγ as a potential mediator in vascular disease. Arterioscler. Thromb. Vasc. Biol. 19; 546-551.
15. Matsuura, E., Kobayashi, K., Tabuchi, M. and Lopez, L. R. (2006) Oxidative modification of low density lipoprotein and immune regulation of atherosclerosis. Prog. Lipid Res. 45; 466-486.
16. Murthy, S., Born, E., Mathur, S. and Field, F. J. (1998) 13-Hydroxyoctadecadienoic acid (13-HODE) inhibits triacylglycerol-rich lipoprotein secretion by CaCo-2 cells. J. Lipid Res. 39; 1254-1262.
17. Nagy, L., Tontonoz, P., Alvarez, J. G. A., Chen, H. and Evans, R. M. (1998) Oxidized LDL regulates macrophage gene expression through ligand activation of PPARγ. Cell 93; 229-240.
18. Nixon, J. B., Kim, K.-S., Lamb, P. W., Bottone, F. G. Jr and Eling, T. E. V. (2004) 15-Lipoxygenase-1 has anti-tumorigenic effects in colorectal cancer. Prostaglandins Leukotriens Essential Acids 70; 7-15.
19. Oliw, E. H., Brodowsky, I. D., Hörnsten, L. and Hamberg, M. (1993) Bis-Allylic hydroxylation of polyunsaturated fatty acids by hepatic mono oxygenases and its relation to the enzymatic and nonenzymatic formation of conjugated hydroxyl fatty acids. Arch. Biochem. Biophys. 300; 434-439.
20. Shureiqi, I., Wojno, K. J., Poore, J. A., Reddy, R. G., Moussalli, M. J., Spindler, S. A., Greenson, J. K., Normolle, D., Hasan, A. A. K., Lawrence, T. S. and Brenner, D. E. (1999) Decreased 13-S-hydroxyoctadecadienoic acid levels and 15-lipoxygenase-1 expression in human colon cancer cells. Carcinogenesis 20; 1985-1995.
21. Staprans, I., Pan, X.-M., Rapp, J. H. and Feingold, K. R. (2005) The role of dietary oxidized cholesterol and oxidized fatty acids in the development of atherosclerosis. Mol. Nutr. Food Res. 49; 1075-1082.
22. Stoll, G. and Bendszus, M. (2006) Inflammation and atherosclero-sis: novel insights into plaque formation and destabilization. Stroke 37; 1923-1932.
23. Takayama, H., Gimbrone, Jr. M. A. and Schafer, A. I. (1987) Vascular lipoxygenase activity: synthesis of 15-hydroxyeicosa-tetraenoic acid from arachidonic acid by blood vessels and cultured endothelial cells. Thromb. Res. 45; 803-816.
24. Tontonoz, P., Nagy, L., Alvarez, J. G. A., Thomazy, V. A. and Evans, R. M. (1998) PPARγ promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell 93; 241-252.
25. Wittwer, J. and Hersberger, M. (2007) The two faces of the 15-lipoxygenase in atherosclerosis. Prostglandins Leukotriens Essential Fatty Acids 77; 67-77.